Kovack Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.59M | Sell |
4,406
-415
| -9% | -$142K | 0.08% | 259 |
|
|
2026
Q1 | $1.7M | Sell |
4,821
-101
| -2% | -$36K | 0.09% | 224 |
|
|
2025
Q4 | $1.61M | Buy |
4,922
+3,353
| +214% | +$1.06M | 0.07% | 247 |
|
|
2025
Q3 | $443K | Hold |
1,569
| – | – | 0.04% | 362 |
|
|
2025
Q2 | $438K | Buy |
1,569
+88
| +6% | +$24.9K | 0.04% | 370 |
|
|
2025
Q1 | $461K | Sell |
1,481
-123
| -8% | -$36.3K | 0.05% | 319 |
|
|
2024
Q4 | $418K | Buy |
1,604
+2
| +0.1% | +$593 | 0.04% | 352 |
|
|
2024
Q3 | $516K | Sell |
1,602
-552
| -26% | -$181K | 0.05% | 293 |
|
|
2024
Q2 | $673K | Sell |
2,154
-1,540
| -42% | -$452K | 0.07% | 243 |
|
|
2024
Q1 | $1.05M | Buy |
3,694
+711
| +24% | +$208K | 0.13% | 143 |
|
|
2023
Q4 | $859K | Buy |
2,983
+141
| +5% | +$38.4K | 0.1% | 191 |
|
|
2023
Q3 | $764K | Sell |
2,842
-167
| -6% | -$41.7K | 0.11% | 182 |
|
|
2023
Q2 | $668K | Sell |
3,009
-938
| -24% | -$218K | 0.09% | 226 |
|
|
2023
Q1 | $954K | Buy |
3,947
+488
| +14% | +$120K | 0.13% | 157 |
|
|
2022
Q4 | $908K | Sell |
3,459
-264
| -7% | -$70.8K | 0.13% | 160 |
|
|
2022
Q3 | $839K | Sell |
3,723
-1,106
| -23% | -$268K | 0.12% | 175 |
|
|
2022
Q2 | $1.18M | Buy |
4,829
+916
| +23% | +$224K | 0.16% | 139 |
|
|
2022
Q1 | $946K | Buy |
3,913
+1,281
| +49% | +$294K | 0.1% | 223 |
|
|
2021
Q4 | $592K | Sell |
2,632
-113
| -4% | -$23.8K | 0.06% | 349 |
|
|
2021
Q3 | $584K | Sell |
2,745
-15
| -0.5% | -$3.45K | 0.06% | 335 |
|
|
2021
Q2 | $673K | Sell |
2,760
-15
| -0.5% | -$3.69K | 0.08% | 281 |
|
|
2021
Q1 | $690K | Buy |
2,775
+80
| +3% | +$19.1K | 0.09% | 245 |
|
|
2020
Q4 | $620K | Buy |
2,695
+23
| +0.9% | +$5.3K | 0.09% | 236 |
|
|
2020
Q3 | $679K | Buy |
2,672
+147
| +6% | +$36.4K | 0.12% | 186 |
|
|
2020
Q2 | $596K | Sell |
2,525
-141
| -5% | -$32.2K | 0.12% | 190 |
|
|
2020
Q1 | $541K | Buy |
+2,666
| New | +$582K | 0.12% | 181 |
|
|
2019
Q4 | – | Sell |
-3,515
| Closed | -$680K | – | 483 |
|
|
2019
Q3 | $680K | Sell |
3,515
-214
| -6% | -$41.1K | 0.14% | 171 |
|
|
2019
Q2 | $687K | Sell |
3,729
-1,171
| -24% | -$210K | 0.16% | 154 |
|
|
2019
Q1 | $931K | Sell |
4,900
-1,295
| -21% | -$247K | 0.23% | 112 |
|
|
2018
Q4 | $1.21M | Buy |
6,195
+1,536
| +33% | +$300K | 0.35% | 74 |
|
|
2018
Q3 | $966K | Buy |
4,659
+279
| +6% | +$55K | 0.25% | 102 |
|
|
2018
Q2 | $808K | Sell |
4,380
-1,774
| -29% | -$314K | 0.23% | 115 |
|
|
2018
Q1 | $1.05M | Sell |
6,154
-138
| -2% | -$25.3K | 0.26% | 90 |
|
|
2017
Q4 | $1.09M | Sell |
6,292
-259
| -4% | -$45.8K | 0.28% | 82 |
|
|
2017
Q3 | $1.22M | Buy |
6,551
+233
| +4% | +$41.3K | 0.41% | 54 |
|
|
2017
Q2 | $1.09M | Buy |
6,318
+1,985
| +46% | +$323K | 0.34% | 59 |
|
|
2017
Q1 | $711K | Buy |
4,333
+161
| +4% | +$26.8K | 0.28% | 88 |
|
|
2016
Q4 | $610K | Buy |
4,172
+329
| +9% | +$49.5K | 0.29% | 78 |
|
|
2016
Q3 | $641K | Buy |
3,843
+88
| +2% | +$14.9K | 0.31% | 82 |
|
|
2016
Q2 | $571K | Sell |
3,755
-2,309
| -38% | -$359K | 0.3% | 80 |
|
|
2016
Q1 | $909K | Buy |
6,064
+2,227
| +58% | +$331K | 0.57% | 43 |
|
|
2015
Q4 | $623K | Buy |
3,837
+111
| +3% | +$17.4K | 0.41% | 66 |
|
|
2015
Q3 | $515K | Buy |
3,726
+1,843
| +98% | +$291K | 0.36% | 73 |
|
|
2015
Q2 | $289K | Buy |
+1,883
| New | +$302K | 0.2% | 134 |
|
Other funds holding AMGN
Kovack Advisors's AMGN Position: Q2 2026 in Review
Kovack Advisors reduced its Amgen (AMGN) stake by 8.6% in Q2 2026, selling an estimated $142K and leaving 4,406 shares worth $1.59M. The position accounts for 0.08% of the portfolio, ranked #259.
Kovack Advisors first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.7M in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Kovack Advisors held 4,406 shares of Amgen worth $1.59M as of Q2 2026.
- Kovack Advisors sold 415 Amgen shares in Q2 2026, an estimated $142K.
- Amgen made up 0.08% of Kovack Advisors's portfolio in Q2 2026, its #259 holding.
- Kovack Advisors first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
- Kovack Advisors's Amgen position peaked at $1.7M in Q1 2026.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.